- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04468503
Comparative Effect of Protein Prescription Strategies on Nitrogen Balance and Upshots in Critically Ill Patients
Study Overview
Status
Conditions
Detailed Description
STUDY DESIGN This is the prospective interventional randomized controlled trial in which effect of protein prescription on UUN and clinical outcome of critically ill patients enroll in the study will compare The NUTRIC scores will be calculated manually, based on data from the medical records of critically ill patients.This trail will be conducted in three stages.
In Phase I all admitted patients in critical care unit will be screen by. APACHE II NUTRIC Score Phase II: Patients with nutrition risk will randomly divided into two group (1:1) Interventional Group None Interventional Group Phase III: Follow the patient for 28 days after discharge from Hospital. Study Locale The study will be conducted in the ICUs (SICUs, MICUs, HDU) of Hospital in Islamabad, for this study organizational approval from formal ethical committee will be taken during the time period of six months.
STATISTICAL METHODS:
Descriptive statistics will be use for demographic data and over all outcomes, further more analytical stat will be used to the type of variables and objective of the study. Z test will be use for the comparison of quantitative variables and Chi square test will be use for categorical data. A NOVA will be use where applicable
.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zainab Bibi, M.phill
- Phone Number: 03349103415
- Email: bibi_zainab@yahoo.com
Study Contact Backup
- Name: Dr.Rezzan Khan, phd
- Phone Number: 03455267371
- Email: rezzankhan@hotmail.com
Study Locations
-
-
Federal
-
Islamabad, Federal, Pakistan, 46000
- Allama Iqbal Open University
-
Contact:
- Zainab Bibi, M.phill
- Phone Number: 03349103415
- Email: bibi_zainab@yahoo.com
-
Contact:
- Mahparah Safdar, Phd
- Phone Number: 03005610162
- Email: mahpara.jadoon@aiou.edu.pk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Critically ill patient with nutritional risk Age >18 years Pt. ICU stay> 48hrs
Exclusion Criteria:
Patients on ventilator > 72 h < 48 hrs.' stay in ICU Withdrawal of life support within 7 days of randomization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1 g per kg body weight per day
Protein will be receive by patients that is 1g per kg per day, Patients will be assess and according to patient actual dry weight 1 g per kg of that weight protein will provided, energy will be provided according to ASPEN guideline 2016. Base line characters(BMI, nitrogen Balance, Protein biomarker, LFTs, RFTs, GCS) |
In this study intervention will be the dose of protein, one group will be prescribed with the protein dose (1 g/kg/day) and other group will be on prescribed higher dose (2gm/kg/day) of protein according to the ASPEN guideline for critically ill and the energy requirements (other than proteins) will be 25 kcal/kg of adjusted body weight (Picolo et al.,).
Each subject in the trail will provide remaining medical nutrition therapy according to the therapeutic guidelines in the field.
The medical nutrition management other than protein will be adjust according to need of each patient.
|
Active Comparator: 2 g per kg body weight per day
Protein will be receive by patients that is 2g per kg per day, Patients will be assess and according to patient actual dry weight 1 g per kg of that weight protein will provided, energy will be provided according to ASPEN guideline 2016. Base line characters(BMI, nitrogen Balance, Protein bio marker, LFTs. , RFTs, GCS) |
In this study intervention will be the dose of protein, one group will be prescribed with the protein dose (1 g/kg/day) and other group will be on prescribed higher dose (2gm/kg/day) of protein according to the ASPEN guideline for critically ill and the energy requirements (other than proteins) will be 25 kcal/kg of adjusted body weight (Picolo et al.,).
Each subject in the trail will provide remaining medical nutrition therapy according to the therapeutic guidelines in the field.
The medical nutrition management other than protein will be adjust according to need of each patient.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in nitrogen balance
Time Frame: for base line is within 24hours og randomization,for nitrogen balence reassessment every 72 hourly
|
change in nitrogen balance from baseline.
|
for base line is within 24hours og randomization,for nitrogen balence reassessment every 72 hourly
|
Readmission in hospital within 30 days of discharge.
Time Frame: 30 days after discharg
|
Patient will be followed for 30 days after discharge from hospital for monitoring, e.g.
readmission in hospital Mortality ratio
|
30 days after discharg
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SOFA Score,
Time Frame: 72hrly till ICU saty
|
this tool will be use to track a person's status during the stay in an critical care unit (ICU) to determine the extent of a person's organ function or rate of failure.
|
72hrly till ICU saty
|
protein bio markers
Time Frame: 72hrly till ICU saty
|
Blood Urea Nitrogen, Albumin, C- reactive protien
|
72hrly till ICU saty
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Dr. Mahpara Safdar, phd, Allama Iqbal Open University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEC acadmic research
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on Two differnt protien prescription (ig per kg per day and 2g per kg /day )will be assigned to each group interventional
-
The Cleveland ClinicMerck Sharp & Dohme LLCNot yet recruiting
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Assistance Publique - Hôpitaux de ParisAction Research GroupTerminatedDepression | Coronary Artery DiseaseFrance
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States